KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Elevance Health (ELV) Deferred Taxes (2016 - 2025)

Elevance Health (ELV) has disclosed Deferred Taxes for 16 consecutive years, with -$322.0 million as the latest value for Q4 2025.

Quarterly Deferred Taxes fell 177.59% to -$322.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$279.0 million through Dec 2025, up 25.4% year-over-year, with the annual reading at -$279.0 million for FY2025, 25.4% up from the prior year.
Deferred Taxes for Q4 2025 was -$322.0 million at Elevance Health, down from $269.0 million in the prior quarter.
The five-year high for Deferred Taxes was $269.0 million in Q3 2025, with the low at -$322.0 million in Q4 2025.
Average Deferred Taxes over 5 years is -$51.4 million, with a median of -$68.5 million recorded in 2022.
The sharpest move saw Deferred Taxes tumbled 1400.0% in 2021, then soared 1700.0% in 2023.
Over 5 years, Deferred Taxes stood at $228.0 million in 2021, then tumbled by 70.18% to $68.0 million in 2022, then tumbled by 454.41% to -$241.0 million in 2023, then soared by 51.87% to -$116.0 million in 2024, then plummeted by 177.59% to -$322.0 million in 2025.
According to Business Quant data, Deferred Taxes over the past three periods came in at -$322.0 million, $269.0 million, and -$52.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.